A randomized, placebo-controlled study of high-dose baclofen in alcohol-dependent patients - The ALPADIR Study

M. REYNAUD ; H. J. AUBIN ; F. TRINQUET ; B. ZAKINE ; C. DANO ; M. DEMATTEIS ; B. TROJAK ; F. PAILLE ; M. DETILLEUX | 2017
Dans Alcohol and Alcoholism (Vol.52, n°4, July 2017) Article : Périodique

Aims: Alcohol dependence is a major public health issue with a need for new pharmacological treatments. The ALPADIR study assessed the efficacy and safety of baclofen at the target dose of 180 mg/day for the maintenance of abstinence and the red[...]

Plus d'info

Ajouter à la sélection